KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 44 filers reported holding KURA ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $35,812,999 | -1.7% | 1,738,974 | +1.9% | 0.00% | 0.0% |
Q1 2024 | $36,421,054 | +52.9% | 1,707,274 | +3.1% | 0.00% | +50.0% |
Q4 2023 | $23,816,111 | +65.5% | 1,656,009 | +4.9% | 0.00% | 0.0% |
Q3 2023 | $14,392,719 | +2.4% | 1,577,956 | +18.8% | 0.00% | 0.0% |
Q2 2023 | $14,051,474 | -10.7% | 1,328,116 | +3.2% | 0.00% | 0.0% |
Q1 2023 | $15,734,392 | +103029.0% | 1,286,540 | +4.6% | 0.00% | 0.0% |
Q4 2022 | $15,257 | -99.9% | 1,229,430 | +3.3% | 0.00% | 0.0% |
Q3 2022 | $16,252,000 | -26.4% | 1,189,755 | -1.2% | 0.00% | -33.3% |
Q2 2022 | $22,075,000 | +23.9% | 1,204,310 | +8.7% | 0.00% | +50.0% |
Q1 2022 | $17,813,000 | +5.7% | 1,107,777 | -8.0% | 0.00% | 0.0% |
Q4 2021 | $16,853,000 | -18.5% | 1,203,826 | +9.1% | 0.00% | -33.3% |
Q3 2021 | $20,673,000 | -13.8% | 1,103,760 | -4.0% | 0.00% | 0.0% |
Q2 2021 | $23,980,000 | -22.0% | 1,150,157 | +5.8% | 0.00% | -40.0% |
Q1 2021 | $30,742,000 | -5.4% | 1,087,457 | +9.2% | 0.01% | 0.0% |
Q4 2020 | $32,512,000 | +27.1% | 995,491 | +19.3% | 0.01% | 0.0% |
Q3 2020 | $25,571,000 | +111.8% | 834,580 | +12.6% | 0.01% | +66.7% |
Q2 2020 | $12,076,000 | +108.9% | 740,868 | +27.5% | 0.00% | +50.0% |
Q1 2020 | $5,780,000 | -59.6% | 580,984 | -44.2% | 0.00% | +100.0% |
Q4 2019 | $14,302,000 | +88.9% | 1,040,284 | +108.5% | 0.00% | -50.0% |
Q3 2019 | $7,570,000 | -12.9% | 499,032 | +13.1% | 0.00% | 0.0% |
Q2 2019 | $8,689,000 | +40.1% | 441,330 | +18.1% | 0.00% | 0.0% |
Q1 2019 | $6,201,000 | -37.6% | 373,784 | -47.2% | 0.00% | 0.0% |
Q4 2018 | $9,940,000 | +82.8% | 708,020 | +127.8% | 0.00% | 0.0% |
Q3 2018 | $5,439,000 | +8.7% | 310,805 | +13.0% | 0.00% | 0.0% |
Q2 2018 | $5,005,000 | +14.4% | 275,011 | +17.9% | 0.00% | +100.0% |
Q1 2018 | $4,374,000 | +71.3% | 233,331 | +39.8% | 0.00% | 0.0% |
Q4 2017 | $2,553,000 | +4.4% | 166,914 | +2.0% | 0.00% | 0.0% |
Q3 2017 | $2,446,000 | +260.8% | 163,659 | +124.4% | 0.00% | – |
Q2 2017 | $678,000 | +55.1% | 72,919 | +46.8% | 0.00% | – |
Q1 2017 | $437,000 | +50.7% | 49,682 | +0.9% | 0.00% | – |
Q4 2016 | $290,000 | -5.2% | 49,256 | +0.6% | 0.00% | – |
Q3 2016 | $306,000 | – | 48,972 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |